Delaware
|
|
20-3483933
|
(State
or other jurisdiction of
|
|
(I.R.S.
Employer
|
incorporation
or organization)
|
|
Identification
No.)
|
|
|
|
20
Marshall Street #104
|
|
|
South
Norwalk, CT
|
|
06854
|
(Address
of principal executive offices)
|
|
(Zip
code)
|
|
|
|
Part
I: Financial Information
|
|
|
|
Item
1. Condensed Financial Statements (Unaudited):
|
|
|
|
Condensed
Balance Sheets
|
3
|
|
|
Condensed
Statements of Income
|
4
|
|
|
Condensed
Statements of Stockholders’ Equity
|
5
|
|
|
Condensed
Statements of Cash Flows
|
6
|
|
|
Notes
to Condensed Financial Statements
|
7
|
|
|
15
|
|
|
|
17
|
|
|
|
Item
4. Controls and Procedures
|
17
|
|
|
17
|
|
|
|
17
|
|
|
|
Item
6. Exhibits
|
17
|
|
|
Signatures
|
18
|
|
October
31, 2007
|
July
31, 2007
|
||||||
(Unaudited)
|
|||||||
ASSETS
|
|||||||
CURRENT
ASSETS:
|
|||||||
Cash
and cash equivalents
|
$
|
3,145,314
|
$
|
1,035,420
|
|||
Investments
held in Trust (Notes 1 and 3)
|
221,305,176
|
221,416,629
|
|||||
Prepaid
insurance and other expenses
|
182,704
|
213,542
|
|||||
Total
current assets
|
224,633,194
|
222,665,591
|
|||||
TOTAL
ASSETS
|
$
|
224,633,194
|
$
|
222,665,591
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
CURRENT
LIABILITIES:
|
|||||||
Accounts
payable and accrued expenses
|
$
|
61,168
|
$
|
38,998
|
|||
Taxes
payable
|
1,145,014
|
690,189
|
|||||
Note
payable, current portion (Note 7)
|
108,736
|
108,736
|
|||||
Total
current liabilities
|
1,314,918
|
837,923
|
|||||
LONG
TERM LIABILITIES
|
|||||||
Note
payable, long term (Note 7)
|
45,307
|
72,492
|
|||||
COMMON
STOCK SUBJECT TO POSSIBLE CONVERSION
|
|||||||
(8,351,465
shares at conversion value) (Note 1)
|
66,903,031
|
66,427,592
|
|||||
COMMITMENTS
(Note 5)
|
-
|
-
|
|||||
STOCKHOLDERS'
EQUITY (Notes 2, and 6):
|
|||||||
Preferred
stock, $0.0001 par value, 5,000,000 shares authorized, 0
issued
|
|||||||
and
outstanding
|
|||||||
Common
stock, par value $0.0001 per share, 100,000,000 shares
|
|||||||
authorized,
25,746,035 shares issued and outstanding (excluding
|
|||||||
8,351,465
shares subject to conversion)
|
2,575
|
2,575
|
|||||
Additional
paid-in capital
|
153,811,381
|
154,286,820
|
|||||
Earnings
accumulated in the development stage
|
2,555,982
|
1,038,189
|
|||||
TOTAL
STOCKHOLDERS’ EQUITY
|
156,369,938
|
155,327,584
|
|||||
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY
|
$
|
224,633,194
|
$
|
222,665,591
|
|||
For
the three
|
For
the three
|
From
September 9,
|
||||||||||
months ended
|
months ended
|
2005
(inception)
|
||||||||||
October
31, 2007
|
October
31, 2006
|
to
October 31, 2007
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
Operating
Expenses
|
||||||||||||
Formation
and administrative costs (Notes 4 and 5)
|
$ |
142,144
|
$ |
2,116
|
$ |
284,099
|
||||||
Loss
from operations
|
(142,144 | ) | (2,116 | ) | (284,099 | ) | ||||||
Other
income (expense)
|
||||||||||||
Interest
income (Note 1)
|
2,806,883
|
15,402
|
4,647,764
|
|||||||||
Interest
expense (Note 7)
|
(1,916 | ) |
-
|
(3,193 | ) | |||||||
Income
before provision for income taxes
|
2,662,823
|
13,286
|
4,360,472
|
|||||||||
Provision
for federal and state income taxes (Note 4)
|
1,145,030
|
5,049
|
1,804,490
|
|||||||||
Net
income for the period
|
$ |
1,517,793
|
$ |
8,237
|
$ |
2,555,982
|
||||||
Accretion
of Trust Fund relating to
|
||||||||||||
common
stock subject to possible conversion
|
(475,439 | ) |
-
|
(793,180 | ) | |||||||
Net
income attributable to common stockholders
|
$ |
1,042,354
|
$ |
8,237
|
$ |
1,762,802
|
||||||
Shares
outstanding subject to possible conversion
|
8,351,465
|
-
|
||||||||||
Net
income per share subject to possible
|
||||||||||||
conversion,
basic and diluted
|
$ |
0.06
|
$ |
-
|
||||||||
Weighted
average number of shares outstanding
|
25,746,035
|
6,250,000
|
||||||||||
Net
income per share:
|
||||||||||||
Basic
and diluted
|
$ |
0.04
|
$ |
0.00
|
||||||||
(Deficit)
Earnings Accumulated in
|
||||||||||||||||||||
Common
stock
|
Additional
|
the
Development
|
||||||||||||||||||
Shares
|
Amount
|
Paid-In-Capital
|
Stage
|
Total
|
||||||||||||||||
Balance,
September 9, 2005 (inception)
|
-
|
$ |
-
|
$ |
-
|
$ |
-
|
$ |
-
|
|||||||||||
Issuance
of Common Stock to initial stockholder
|
100
|
-
|
1
|
-
|
1
|
|||||||||||||||
Issuance
of 8,150,000 warrants at $0.05
|
||||||||||||||||||||
per
warrant
|
-
|
-
|
407,500
|
-
|
407,500
|
|||||||||||||||
Issuance
of 4,075,000 Class Z warrants and
|
||||||||||||||||||||
4,075,000
Class W warrants with an
|
||||||||||||||||||||
aggregate
value of $407,500 in exchange
|
||||||||||||||||||||
for
the cancellation of 8,150,000 warrants
|
||||||||||||||||||||
with
an aggregate value of $407,500
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||
Issuance
of 700,000 Class Z warrants and
|
||||||||||||||||||||
700,000
Class W warrants at $0.05 per
|
||||||||||||||||||||
warrant
|
-
|
-
|
70,000
|
-
|
70,000
|
|||||||||||||||
Issuance
of 6,925,000 Class Z warrants and
|
||||||||||||||||||||
6,925,000
Class W warrants at $0.05 per
|
||||||||||||||||||||
warrant
|
-
|
-
|
692,500
|
-
|
692,500
|
|||||||||||||||
Net
loss for the period
|
-
|
-
|
-
|
(2,230 | ) | (2,230 | ) | |||||||||||||
Balance,
July 31, 2006
|
100
|
$ |
-
|
$ |
1,170,001
|
$ | (2,230 | ) | $ |
1,167,771
|
||||||||||
Issuance
of 3,800,000 Class Z warrants and
|
||||||||||||||||||||
3,800,000
Class W warrants at $0.05 per
|
||||||||||||||||||||
warrant
|
-
|
-
|
380,000
|
-
|
380,000
|
|||||||||||||||
Issuance
of common stock to initial stockholders
|
||||||||||||||||||||
with
an aggregate value of $1,550,000 in exchange
|
||||||||||||||||||||
for
the return and cancellation of 15,500,000
|
||||||||||||||||||||
Class
Z warrants and 15,500,000 Class W warrants
|
||||||||||||||||||||
with
an aggregate value of $1,550,000
|
6,249,900
|
625
|
(625 | ) |
-
|
-
|
||||||||||||||
Proceeds
from sale of underwriter purchase option
|
100
|
100
|
||||||||||||||||||
Proceeds
from issuance of insider warrants
|
4,450,000
|
4,450,000
|
||||||||||||||||||
Sale
of 27,847,500 units through public
|
||||||||||||||||||||
offering
net of underwriter discount
|
||||||||||||||||||||
offering
expenses and excluding $66,109,851 of
|
||||||||||||||||||||
proceeds
allocable to 8,351,465 shares
|
||||||||||||||||||||
of
common stock subject to possible conversion
|
19,496,035
|
1,950
|
148,605,085
|
-
|
148,607,035
|
|||||||||||||||
Accretion
of trust fund relating to common stock
|
||||||||||||||||||||
subject
to possible conversion
|
(317,741 | ) | (317.,741 | ) | ||||||||||||||||
Net
income for the year
|
-
|
-
|
-
|
1,040,419
|
1,040,419
|
|||||||||||||||
Balance,
July 31, 2007
|
25,746,035
|
$
|
2,575
|
$
|
154,286,820
|
$ |
1,038,189
|
$ |
155,327,584
|
|||||||||||
Accretion
of trust fund relating to common stock
|
||||||||||||||||||||
subject
to possible conversion (Unaudited)
|
-
|
-
|
(475,439 | ) |
-
|
(475,439 | ) | |||||||||||||
Net
income for the period (Unaudited)
|
1,517,793
|
1,517,793
|
||||||||||||||||||
Balance,
October 31, 2007 (Unaudited)
|
25,746,035
|
$
|
2,575
|
$
|
153,811,381
|
$
|
2,555,982
|
$
|
156,369,938
|
For
the three
|
For
the three
|
From
September 9,
|
||||||||||
months
ended
|
months
ended
|
2005
(inception) to
|
||||||||||
October
31, 2007
|
October
31, 2006
|
October
31, 2007
|
||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
||||||||||
OPERATING
ACTIVITIES
|
||||||||||||
Net
income for the period
|
$ |
1,517,793
|
$ |
8,237
|
$ |
2,555,982
|
||||||
Decrease
(increase) in investments held in trust fund
|
111,453
|
-
|
(865,526 | ) | ||||||||
Adjustments
to reconcile net income to net cash provided
by
|
||||||||||||
operating
activities
|
||||||||||||
Changes
in:
|
||||||||||||
Prepaid
insurance and other expenses
|
30,838
|
-
|
16,647
|
|||||||||
Accrued
payable and accrued expenses
|
22,170
|
25,843
|
49,630
|
|||||||||
Taxes
payable
|
454,825
|
5,049
|
1,145,014
|
|||||||||
Net
cash provided by operating activities
|
2,137,079
|
39,129
|
2,901,747
|
|||||||||
INVESTING
ACTIVITIES
|
||||||||||||
Purchase
of investments held in Trust Fund
|
(2,892,723 | ) |
-
|
(444,749,002 | ) | |||||||
Maturities
of investments held in Trust Fund
|
2,892,723
|
-
|
224,309,352
|
|||||||||
Net
cash used in investing activities
|
-
|
-
|
(220,439,650 | ) | ||||||||
FINANCING
ACTIVITIES
|
||||||||||||
Proceeds
from issuance of common stock to initial stockholders
|
-
|
-
|
1
|
|||||||||
Proceeds
from issuance of insider warrants in private placement
|
-
|
-
|
4,450,000
|
|||||||||
Proceeds
from issuance of underwriter’s purchase option
|
-
|
-
|
100
|
|||||||||
Portion
of net proceeds from sale of units through public offering
|
||||||||||||
allocated
to shares of common stock subject to possible conversion
|
-
|
-
|
66,109,851
|
|||||||||
Proceeds
from issuance of warrants to security holders
|
-
|
-
|
1,550,000
|
|||||||||
Principal
payment on notes
|
(27,185 | ) |
-
|
(45,308 | ) | |||||||
Payment
of deferred registration costs
|
-
|
(23,922 | ) | (260,594 | ) | |||||||
Net
proceeds from sale of units through public offering
|
||||||||||||
including
the proceeds from underwriter over-allotment exercise
|
-
|
-
|
148,879,167
|
|||||||||
Net
cash provided by financing activities
|
(27,185 | ) | (23,922 | ) |
220,683,217
|
|||||||
Net
increase in cash and cash equivalents
|
2,109,894
|
15,207
|
3,145,314
|
|||||||||
Cash
and cash equivalents
|
||||||||||||
Beginning
of period
|
1,035,420
|
912,426
|
-
|
|||||||||
End
of period
|
$ |
3,145,314
|
$ |
927,633
|
$ |
3,145,314
|
||||||
Supplemental
disclosure of non-cash financing activities
|
||||||||||||
Fair
value of underwriter purchase option included in offering
costs
|
$ |
-
|
$ |
-
|
$ |
4,372,000
|
||||||
Accretion
relating to common stock subject to possible conversion
|
$ | (475,439 | ) | $ |
-
|
$ | (793,180 | ) | ||||
Financed
insurance
|
$ |
154,043
|
$ |
-
|
$ |
199,350
|
||||||
Supplemental
disclosure of cash flow information
|
||||||||||||
Cash
paid for interest
|
$ |
1,916
|
$ |
-
|
$ |
3,193
|
||||||
Cash
paid for taxes
|
$ |
690,205
|
$ |
-
|
$ |
695,017
|
|
|
|
|
STONELEIGH
PARTNERS ACQUISITION CORP.
|
|
Dated:
December 14, 2007
|
||
|
By:
|
/s/ Gary
D. Engle
|
|
Gary
D. Engle
Chairman
of the Board and Chief Executive Officer
(Principal
Executive Officer)
|
|
|
|
|
|
|
|
Dated: December 14, 2007
|
||
|
By:
|
/s/ James
A. Coyne
|
|
James
A. Coyne
Chief
Financial Officer and Vice Chairman
(Principal
Financial and Accounting Officer)
|
|
|
|